個別化精神医学の世界市場レポート 2025年

個別化精神医療市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.6％で112億4,000万米ドルに成長します。予測期間における成長の原動力は、デジタル治療の採用拡大、遠隔患者モニタリングのニーズの高まり、情勢変化後のメンタルヘルスソリューションに対する需要の高まり、メンタルヘルスに対する政府・民間セクタの投資の増加、より利用しやすいメンタルヘルスケアサービスの推進などです。この期間に予想される主要動向には、メンタルヘルス診断における人工知能の利用拡大、遠隔精神医療とオンライン診察の人気の高まり、メンタルヘルスデータを保護するためのブロックチェーンの統合、治療アプリケーションにおける仮想現実（VR）の利用拡大、メンタルヘルス用ウェアラブルデバイスの拡大などがあります。

メンタルヘルス問題の有病率の増加は、個別化精神医療市場の拡大を促進すると予想されます。メンタルヘルス問題は、人の感情的、心理的、社会的な幸福に影響を与える幅広い状態を包含します。このような問題の増加は、ストレスレベルの上昇やライフスタイルに関連する課題が主要原因であり、ペースの速い職場環境、ワークライフバランスの悪化、限られた対処メカニズムなどが原因であることが多いです。個別化精神医療では、個人特有の生物学的、心理学的、ライフスタイル的要因に基づいたオーダーメイドの治療計画を提供することで、これらの懸念に対応しています。このアプローチは、治療における試行錯誤を減らすことで治療効果を高め、早期回復と転帰の改善につながります。例えば、米国を拠点とする連邦研究機関である国立精神衛生ラボ（National Institute of Mental Health）は2022年、米国の18歳以上の成人のうち5,930万人が何らかの精神疾患（AMI）に罹患しており、成人人口全体の23.1％を占めると推定しました。したがって、精神衛生問題の増加が個別化精神医療市場の成長を牽引しています。

個別化精神医療市場の主要企業は、患者中心の柔軟なサービスモデルを通じて個別化されたメンタルヘルスケアへのアクセスを改善するため、個別化遠隔精神医療などの先進サービスを開発しています。個別化遠隔精神医療とは、デジタル通信プラットフォームを利用して、個人固有の遺伝的、環境的、ライフスタイル的要因に基づき、カスタマイズ型精神医療的評価と治療を提供する遠隔メンタルヘルスのアプローチです。例えば、2025年4月、米国を拠点とする精神医療ウェルネスサービスプロバイダであるAlice's Psychiatry & Wellnessは、対面診療と遠隔精神医療サービスの両方を通じて、複数の州にまたがる成人に思いやりのある個別化された精神医療を提供するクリニックを開設しました。このクリニックでは、薬理遺伝学的検査を統合し、各患者の遺伝的プロファイルに応じて精神科治療を調整することで、治療効果を高め、副作用を最小限に抑えています。バーチャルプラットフォームを活用し、専任のプロバイダによる継続的なケアを提供することで、このクリニックは個別化精神医療の原則に完全に沿った、アクセスしやすく一貫性のある包括的なメンタルヘルスサポートを保証しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の個別化精神医療 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の個別化精神医療市場：成長率分析
• 世界の個別化精神医療市場の実績：規模と成長、2019～2024年
• 世界の個別化精神医療市場の予測：規模と成長、2024～2029年、2034年
• 世界の個別化精神医療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の個別化精神医療市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 製品
• サービス
• ソフトウェア
• 世界の個別化精神医療市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• 遺伝子検査
• 人工知能
• 神経刺激技術
• デジタルセラピューティクス
• 世界の個別化精神医療市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• うつ
• 不安障害
• 双極性障害
• 統合失調症
• 注意欠陥多動性障害（ADHD）
• 世界の個別化精神医療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• クリニック
• 病院
• 研究機関
• 在宅ケア
• 世界の個別化精神医療市場、製品のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬理ゲノム検査キット
• ウェアラブルデバイス
• 脳画像装置
• 世界の個別化精神医療市場、サービスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• テレサイキアトリー
• 個別治療計画
• 行動評価
• 世界の個別化精神医療市場、ソフトウェアのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 臨床意思決定支援ツール
• メンタルヘルスアプリ
• バーチャルセラピープラットフォーム

第7章 地域別・国別分析

• 世界の個別化精神医療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の個別化精神医療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 個別化精神医療市場：競合情勢
• 個別化精神医療市場：企業プロファイル
  • Johnson & Johnson
  • AbbVie Inc.
  • Bristol-Myers Squibb
  • Medtronic Plc
  • Takeda Pharmaceutical Company

第31章 その他の大手企業と革新的企業

• Boehringer Ingelheim
• Otsuka Pharmaceutical Co. Ltd.
• H. Lundbeck A/S
• Neurocrine Biosciences
• Spring Health
• Neumora Therapeutics Inc.
• Atai Life Sciences
• Valera Health
• Compass Pathways
• Genomind
• Woebot Health
• BrightQuest Treatment Centers
• Meru Health
• Alto Neuroscience
• Arcara Personalized Psychiatry

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 個別化精神医療市場、2029年：新たな機会を提供する国
• 個別化精神医療市場、2029年：新たな機会を提供するセグメント
• 個別化精神医療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Personalized psychiatry is an individualized approach to mental health care that combines genetic, biological, environmental, and clinical information to customize diagnosis, treatment planning, and therapeutic strategies for each patient. This approach aims to improve treatment effectiveness, reduce adverse effects, and enable early intervention by aligning psychiatric care with the unique biological and psychological profile of the individual.

The main categories of personalized psychiatry include products, services, and software. Personalized psychiatry products consist of specialized medical tools, diagnostics, and therapeutic solutions developed to support individualized mental health treatment based on a person's genetic, biological, and behavioral traits. Key technologies in this field include genetic testing, artificial intelligence, neurostimulation technology, and digital therapeutics, which are applied in the management of conditions such as depression, anxiety disorders, bipolar disorder, schizophrenia, and attention-deficit hyperactivity disorder (ADHD). These solutions are used across various settings including clinics, hospitals, research institutes, and homecare environments.

The personalized psychiatry market research report is one of a series of new reports from The Business Research Company that provides personalized psychiatry market statistics, including personalized psychiatry industry global market size, regional shares, competitors with a personalized psychiatry market share, detailed personalized psychiatry market segments, market trends and opportunities, and any further data you may need to thrive in the personalized psychiatry industry. This personalized psychiatry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized psychiatry market size has grown rapidly in recent years. It will grow from $5.69 billion in 2024 to $6.53 billion in 2025 at a compound annual growth rate (CAGR) of 14.8%. The growth during the historic period can be attributed to increased awareness of mental health, a rising prevalence of psychiatric disorders, growing demand for personalized healthcare, higher healthcare expenditures, and improved access to and affordability of healthcare services.

The personalized psychiatry market size is expected to see rapid growth in the next few years. It will grow to $11.24 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period is driven by the expanding adoption of digital therapeutics, a growing need for remote patient monitoring, increasing demand for mental health solutions in the post-COVID-19 landscape, rising government and private sector investments in mental health, and a push for more accessible mental healthcare services. Key trends expected during this period include greater use of artificial intelligence in mental health diagnostics, the rising popularity of telepsychiatry and online consultations, integration of blockchain for securing mental health data, increased use of virtual reality (VR) in therapeutic applications, and the expansion of wearable devices for mental health monitoring.

The growing prevalence of mental health issues is expected to drive the expansion of the personalized psychiatry market. Mental health issues encompass a wide range of conditions that impact a person's emotional, psychological, and social well-being. The increase in these issues is largely attributed to rising stress levels and lifestyle-related challenges, often driven by fast-paced work environments, poor work-life balance, and limited coping mechanisms. Personalized psychiatry addresses these concerns by offering tailored treatment plans based on an individual's unique biological, psychological, and lifestyle factors. This approach enhances the effectiveness of care by reducing trial and error in treatment, leading to quicker recovery and improved outcomes. For example, in 2022, the National Institute of Mental Health, a U.S.-based federal research agency, estimated that 59.3 million adults aged 18 and older in the United States had any mental illness (AMI), accounting for 23.1% of the total adult population. Therefore, the rise in mental health issues is driving the growth of the personalized psychiatry market.

Leading companies in the personalized psychiatry market are developing advanced services, such as personalized telepsychiatry, to improve access to individualized mental health care through flexible, patient-centered service models. Personalized telepsychiatry is a remote mental healthcare approach that delivers customized psychiatric evaluation and treatment based on an individual's unique genetic, environmental, and lifestyle factors using digital communication platforms. For example, in April 2025, Alice's Psychiatry & Wellness, a U.S.-based psychiatry and wellness service provider, launched a clinic to offer compassionate, personalized psychiatric care to adults across multiple states via both in-person and telepsychiatry services. This clinic integrates pharmacogenetic testing to tailor psychiatric medications according to each patient's genetic profile, enhancing treatment effectiveness and minimizing adverse effects. By leveraging virtual platforms and providing continuous care from dedicated providers, the clinic ensures accessible, consistent, and comprehensive mental health support, fully aligned with the principles of personalized psychiatry.

In March 2025, April Health Inc., a U.S.-based behavioral health company, merged with Wysa Ltd. for an undisclosed amount. This merger aims to combine Wysa's AI-driven mental health support with April Health's virtual behavioral health services, enhancing access to personalized behavioral healthcare through primary care providers. Wysa Ltd., a U.S.-based digital mental health company, utilizes artificial intelligence (AI) to deliver personalized, evidence-based psychiatric support.

Major players in the personalized psychiatry market are Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Medtronic Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Neurocrine Biosciences, Spring Health, Neumora Therapeutics Inc., Atai Life Sciences, Valera Health, Compass Pathways, Genomind, Woebot Health, BrightQuest Treatment Centers, Meru Health, Alto Neuroscience, Arcara Personalized Psychiatry, GreyBird Ventures, Mind Sync Therapeutics, Starling Minds, and HMNC Holding GmbH.

North America was the largest region in the personalized psychiatry market in 2024. The regions covered in personalized psychiatry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the personalized psychiatry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized psychiatry market consists of revenues earned by entities by providing services such as remote patient monitoring services for mental health, mental health coaching programs, medication management support, lifestyle and behavioral modification programs, cognitive assessment services, and in-home psychiatric care. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized psychiatry market also includes sales of biomarker-based diagnostic assays, neurofeedback equipment, point-of-care mental health diagnostic tools, personalized supplement formulations, and biosensor-integrated monitoring tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Psychiatry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized psychiatry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized psychiatry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized psychiatry market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Products; Services; Software
• 2) By Technology: Genetic Testing; Artificial Intelligence; Neurostimulation Technology; Digital Therapeutics
• 3) By Application: Depression; Anxiety Disorders; Bipolar Disorder; Schizophrenia; Attention-Deficit Hyperactivity Disorder (ADHD)
• 4) By End User: Clinics; Hospitals; Research Institutes; Homecare Settings
• Subsegments:
• 1) By Products: Pharmacogenomic Test Kits; Wearable Devices; Brain Imaging Devices
• 2) By Services: Telepsychiatry; Personalized Treatment Planning; Behavioral Assessment
• 3) By Software: Clinical Decision Support Tools; Mental Health Apps; Virtual Therapy Platforms
• Companies Mentioned: Johnson & Johnson; AbbVie Inc.; Bristol-Myers Squibb; Medtronic Plc; Takeda Pharmaceutical Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Personalized Psychiatry Market Characteristics

3. Personalized Psychiatry Market Trends And Strategies

4. Personalized Psychiatry Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Personalized Psychiatry Growth Analysis And Strategic Analysis Framework

• 5.1. Global Personalized Psychiatry PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Personalized Psychiatry Market Growth Rate Analysis
• 5.4. Global Personalized Psychiatry Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Personalized Psychiatry Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Personalized Psychiatry Total Addressable Market (TAM)

6. Personalized Psychiatry Market Segmentation

• 6.1. Global Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Products
• Services
• Software
• 6.2. Global Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing
• Artificial Intelligence
• Neurostimulation Technology
• Digital Therapeutics
• 6.3. Global Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Depression
• Anxiety Disorders
• Bipolar Disorder
• Schizophrenia
• Attention-Deficit Hyperactivity Disorder (ADHD)
• 6.4. Global Personalized Psychiatry Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Hospitals
• Research Institutes
• Homecare Settings
• 6.5. Global Personalized Psychiatry Market, Sub-Segmentation Of Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacogenomic Test Kits
• Wearable Devices
• Brain Imaging Devices
• 6.6. Global Personalized Psychiatry Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Telepsychiatry
• Personalized Treatment Planning
• Behavioral Assessment
• 6.7. Global Personalized Psychiatry Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Decision Support Tools
• Mental Health Apps
• Virtual Therapy Platforms

7. Personalized Psychiatry Market Regional And Country Analysis

• 7.1. Global Personalized Psychiatry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Personalized Psychiatry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Psychiatry Market

• 8.1. Asia-Pacific Personalized Psychiatry Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Psychiatry Market

• 9.1. China Personalized Psychiatry Market Overview
• 9.2. China Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Psychiatry Market

• 10.1. India Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Psychiatry Market

• 11.1. Japan Personalized Psychiatry Market Overview
• 11.2. Japan Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Psychiatry Market

• 12.1. Australia Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Psychiatry Market

• 13.1. Indonesia Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Psychiatry Market

• 14.1. South Korea Personalized Psychiatry Market Overview
• 14.2. South Korea Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Psychiatry Market

• 15.1. Western Europe Personalized Psychiatry Market Overview
• 15.2. Western Europe Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Psychiatry Market

• 16.1. UK Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Psychiatry Market

• 17.1. Germany Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Psychiatry Market

• 18.1. France Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Psychiatry Market

• 19.1. Italy Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Psychiatry Market

• 20.1. Spain Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Psychiatry Market

• 21.1. Eastern Europe Personalized Psychiatry Market Overview
• 21.2. Eastern Europe Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Psychiatry Market

• 22.1. Russia Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Psychiatry Market

• 23.1. North America Personalized Psychiatry Market Overview
• 23.2. North America Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Psychiatry Market

• 24.1. USA Personalized Psychiatry Market Overview
• 24.2. USA Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Psychiatry Market

• 25.1. Canada Personalized Psychiatry Market Overview
• 25.2. Canada Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Psychiatry Market

• 26.1. South America Personalized Psychiatry Market Overview
• 26.2. South America Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Psychiatry Market

• 27.1. Brazil Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Psychiatry Market

• 28.1. Middle East Personalized Psychiatry Market Overview
• 28.2. Middle East Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Psychiatry Market

• 29.1. Africa Personalized Psychiatry Market Overview
• 29.2. Africa Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Psychiatry Market Competitive Landscape And Company Profiles

• 30.1. Personalized Psychiatry Market Competitive Landscape
• 30.2. Personalized Psychiatry Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Psychiatry Market Other Major And Innovative Companies

• 31.1. Boehringer Ingelheim
• 31.2. Otsuka Pharmaceutical Co. Ltd.
• 31.3. H. Lundbeck A/S
• 31.4. Neurocrine Biosciences
• 31.5. Spring Health
• 31.6. Neumora Therapeutics Inc.
• 31.7. Atai Life Sciences
• 31.8. Valera Health
• 31.9. Compass Pathways
• 31.10. Genomind
• 31.11. Woebot Health
• 31.12. BrightQuest Treatment Centers
• 31.13. Meru Health
• 31.14. Alto Neuroscience
• 31.15. Arcara Personalized Psychiatry

32. Global Personalized Psychiatry Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Psychiatry Market

34. Recent Developments In The Personalized Psychiatry Market

35. Personalized Psychiatry Market High Potential Countries, Segments and Strategies

• 35.1 Personalized Psychiatry Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Personalized Psychiatry Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Personalized Psychiatry Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer